Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Aptose Biosciences Inc. (T.APS) had Stock-Based Compensation of 0.67M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-10.84M |
|
-- |
|
-- |
|
-- |
|
-10.37M |
|
-- |
|
-10.84M |
|
-10.84M |
|
-10.84M |
|
-10.84M |
|
-10.84M |
|
-10.84M |
|
-10.37M |
|
-10.77M |
|
2.45M |
|
2.45M |
|
-4.21 |
|
-4.21 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
13.99M |
|
-- |
|
-- |
|
-- |
|
51.97M |
|
-37.97M |
|
-37.97M |
|
-37.97M |
|
2.55M |
|
| Cash Flow Statement Financials | |
-30.74M |
|
-- |
|
27.09M |
|
9.37M |
|
5.72M |
|
-3.65M |
|
|
Stock-Based Compensation |
0.67M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
28.54% |
|
28.54% |
|
-77.44% |
|
28.54% |
|
-14.88 |
|
-12.56 |
|
-12.56 |
|